Quality Means Business Secures $2M Seed Funding to Launch AI‑Driven MedTech SaaS Platform

Why It Matters

The funding gives QMB resources to address a critical bottleneck in medical‑device development—regulatory compliance—potentially accelerating time‑to‑market and reducing costs for innovators. Success could set a new standard for AI‑enabled regulatory solutions across the MedTech industry.

Deal Summary

Boston‑based Quality Means Business announced the closing of a $2 million seed round led by The Boston Foundation’s Business Equity Investment Fund and CEI Ventures. The funding will support the launch of QualiVerse, an AI‑powered regulatory intelligence engine for medical device innovators.